Ann: Quarterly Activity Report and Appendix 4C for Q2 FY2022, page-20

i agree, just want add 4DX has the most potential among speculative stocks and most likely to succeed like COH & PME. Delays in clinical trials due to covid and overwhelming hospitals is frustrating but understandable. We're not kept in the dark CEO in many presentations made everything clear about commercialisation and other products pipeline, now its just a waiting game as we already know what to expect for the future.

I was an early investor i hold decent parcel and now im down a lot. I don't always have thousands of dollars in my account ready to be invested, so even if im down now im still happy with the amount of shares i hold. Now If tomorrow the SP hits $ 5 or $ 10 on a US contract announcement, im not sure about others but i will not be selling.
If SP is a dollar or five its OBVIOUS 4DX is a speculative LONG HOLD not a trading stock and risks will be always there. Other than share price i welcome other different opinions who disagree or have concerns about management, commercial progress or competitors or whatever just not share price